Authors: Javier Faus-Cotino, Gabriel Reina, Javier Pueyo
Year: 2024
Journal: Viruses
DOI: 10.3390/v16020179
Summary
This paper provides an update on Nipah virus (NiV), a high mortality zoonotic paramyxovirus responsible for numerous outbreaks in South and South-East Asia. Human infection manifests as encephalitis with high mortality rates, and no therapeutic agents or vaccines have been approved for human use.
Key Findings
- NiV is a high mortality zoonotic paramyxovirus
- Human infection manifests as encephalitis with high mortality rates
- No therapeutic agents or vaccines have been approved for human use
Methodology
- Study Type: Review
Topics
Epidemiology, Virology, Public Health
Relevance
The paper highlights the need for research to develop therapeutic and preventive strategies against Nipah virus, an emerging pathogen with high mortality rates.
Source
View the entire paper: File:Viruses-16-00179.pdf